5-aminoimidazole-4-carboxamide-1-beta-4-ribofurano...[J Pediatr Hematol Oncol. 2007] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: J Pediatr Hematol Oncol. 2007 Dec;29(12):805-7. Links

5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICA-riboside) as a targeting agent for therapy of patients with acute lymphoblastic leukemia: are we there and are there pitfalls?

Cronstein BN, Kamen BA.

NYU School of Medicine, New York, New York, USA.

PMID: 18090925 [PubMed - indexed for MEDLINE]

Related articles

5'-aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells.
Neuroscience. 2003; 117(4):811-20.

[Neuroscience. 2003]
Alteration of purine metabolism by AICA-riboside in human B lymphoblasts.
Arch Biochem Biophys. 1990 Nov 1; 282(2):377-85.

[Arch Biochem Biophys. 1990]
Methotrexate enhances the antianabolic and antiproliferative effects of 5-aminoimidazole-4-carboxamide riboside.
Mol Cancer Ther. 2006 Sep; 5(9):2211-7.

[Mol Cancer Ther. 2006]
ReviewPharmacogenomic effects on therapy for acute lymphoblastic leukemia in children.
Pharmacogenomics J. 2003; 3(3):128-35.

[Pharmacogenomics J. 2003]
ReviewAcadesine: the prototype adenosine regulating agent for reducing myocardial ischaemic injury.
Cardiovasc Res. 1993 Jan; 27(1):43-7.

[Cardiovasc Res. 1993]
» See reviews... | » See all...

Recent Activity

Clear Turn Off Turn On

5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICA-riboside) as a targeting agen...5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICA-riboside) as a targeting agent for therapy of patients with acute lymphoblastic leukemia: are we there and are there pitfalls?

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show